Increased epicardial adipose tissue volume predicts insulin resistance and coronary artery disease in non-obese subjects without metabolic syndrome

IJC Metabolic and Endocrine

Volumn 3, Issue , 2014, Pages 14-19

  Narumi, Taro ^a   Watanabe, Tetsu ^a   Iwayama, Tadateru ^a   Kadowaki, Shinpei ^a   Otaki, Yoichiro ^a   Honda, Yuki ^a   Nishiyama, Satoshi ^a   Takahashi, Hiroki ^a   Arimoto, Takanori ^a   Shishido, Tetsuro ^a   Miyamoto, Takuya ^a   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Coronary artery disease; Epicardial adipose tissue; Insulin resistance

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BODY MASS; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; EPICARDIAL ADIPOSE TISSUE VOLUME; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ADIPOSE TISSUE; DIASTOLIC BLOOD PRESSURE; METABOLIC SYNDROME X; OBESITY; SMOKING;

EID: 84901489855     PISSN: 22147624     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcme.2014.03.003     Document Type: Article

References (24)

1. Physical status: the use and interpretation of anthropometry. World Health Organization technical report series 1995, 854:1-452.
2. Patel P., Abate N. Body fat distribution and insulin resistance. Nutrients 2013, 5:2019-2027.
3. Fujimoto W.Y., Newell-Morris L.L., Grote M., Bergstrom R.W., Shuman W.P. Visceral fat obesity and morbidity: NIDDM and atherogenic risk in Japanese American men and women. Int J Obes 1991, 15(Suppl. 2):41-44.
4. Mottillo S., Filion K.B., Genest J., Joseph L., Pilote L., Poirier P., et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010, 56:1113-1132.
5. Frankel D.S., Vasan R.S., D'Agostino R.B., Benjamin E.J., Levy D., Wang T.J., et al. Resistin, adiponectin, and risk of heart failure the Framingham offspring study. J Am Coll Cardiol 2009, 53:754-762.
6. New criteria for 'obesity disease' in Japan. Circ J 2002, 66:987-992.
7. Yoshiike N., Matsumura Y., Zaman M.M., Yamaguchi M. Descriptive epidemiology of body mass index in Japanese adults in a representative sample from the National Nutrition Survey 1990-1994. Int J Obes Relat Metab Disord 1998, 22:684-687.
8. Yoshiike N., Seino F., Tajima S., Arai Y., Kawano M., Furuhata T., et al. Twenty-year changes in the prevalence of overweight in Japanese adults: the National Nutrition Survey 1976-95. Obes Rev 2002, 3:183-190.
9. Yoshiike N., Kaneda F., Takimoto H. Epidemiology of obesity and public health strategies for its control in Japan. Asia Pac J Clin Nutr 2002, 11(Suppl. 8):S727-S731.
10. Iacobellis G., Pistilli D., Gucciardo M., Leonetti F., Miraldi F., Brancaccio G., et al. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine 2005, 29:251-255.
11. Yerramasu A., Dey D., Venuraju S., Anand D.V., Atwal S., Corder R., et al. Increased volume of epicardial fat is an independent risk factor for accelerated progression of sub-clinical coronary atherosclerosis. Atherosclerosis 2012, 220:223-230.
12. Iacobellis G., Leonetti F. Epicardial adipose tissue and insulin resistance in obese subjects. J Clin Endocrinol Metab 2005, 90:6300-6302.
13. Iwayama T., Nitobe J., Watanabe T., Ishino M., Tamura H., Nishiyama S., et al. The role of epicardial adipose tissue in coronary artery disease in non-obese patients. J Cardiol Nov. 11 2013, [pii: S0914-5087(13)00801-8, Epub ahead of print]. 10.1016/j.jjcc.2013.10.002.
14. Mori Y., Hoshino K., Yokota K., Yokose T., Tajima N. Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men. Exp Clin Endocrinol Diabetes 2005, 113:334-339.
15. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
16. Hao Z., Konta T., Takasaki S., Abiko H., Ishikawa M., Takahashi T., et al. The association between microalbuminuria and metabolic syndrome in the general population in Japan: the Takahata study. Intern Med 2007, 46:341-346.
17. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
18. Raff G.L., Abidov A., Achenbach S., Berman D.S., Boxt L.M., Budoff M.J., et al. SCCT guidelines for the interpretation and reporting of coronary computed tomographic angiography. J Cardiovasc Comput Tomogr 2009, 3:122-136.
19. Fujioka S., Matsuzawa Y., Tokunaga K., Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 1987, 36:54-59.
20. Kanai H., Matsuzawa Y., Kotani K., Keno Y., Kobatake T., Nagai Y., et al. Close correlation of intra-abdominal fat accumulation to hypertension in obese women. Hypertension 1990, 16:484-490.
21. Kim H.M., Kim K.J., Lee H.J., Yu H.T., Moon J.H., Kang E.S., et al. Epicardial adipose tissue thickness is an indicator for coronary artery stenosis in asymptomatic type 2 diabetic patients: its assessment by cardiac magnetic resonance. Cardiovasc Diabetol 2012, 11:83.
22. Ashrafian H., Frenneaux M.P., Opie L.H. Metabolic mechanisms in heart failure. Circulation 2007, 116:434-448.
23. Sacks H.S., Fain J.N. Human epicardial adipose tissue: a review. Am Heart J 2007, 153:907-917.
24. Bambace C., Sepe A., Zoico E., Telesca M., Olioso D., Venturi S., et al. Inflammatory profile in subcutaneous and epicardial adipose tissue in men with and without diabetes. Heart Vessels Jan 2014, 29(1):42-48. [Epub 2013 Jan 8]. 10.1007/s00380-012-0315-9.